| MY156858A (en) | | Low-oil pharmaceutical emulsion compositions comprising progestogen |
| BR112014004967A2 (en) | | sustained release lipid preconcentrate and pharmaceutical composition |
| BR112014026493A2 (en) | | imidazotiadiazole derivatives as protease activated receptor 4 (par4) inhibitors to treat platelet aggregation |
| WO2016134223A3 (en) | | Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof |
| WO2011113855A3 (en) | | Pharmaceutical composition for treatment of increased intraocular pressure |
| WO2015081133A3 (en) | | Nucleotides for the treatment of liver cancer |
| MY158504A (en) | | Fatty acid niacin conjugates and their uses |
| GB2491775A (en) | | Pulsatile drug release |
| UA110013C2 (en) | | APPLICATION OF THE COMPOSITION FOR THE TREATMENT OF BALL-MARI-HERE AND THE RELATED DISORDERS |
| MX342257B (en) | | Oxaspiro [2.5] octane derivatives and analogs. |
| MX349974B (en) | | Methods for the treatment or prophylaxis of thrombosis or embolism. |
| MX389600B (en) | | NEW THERAPEUTIC COMPOSITION CONTAINING ACTIVE INGREDIENT OF APOMORPHINS. |
| WO2014107730A3 (en) | | Use of fatty acid niacin conjugates for treating diseases |
| BR112014020271A8 (en) | | PHARMACEUTICAL COMPOSITION AND METHODS TO DECREASE URINATION FREQUENCY IN PATIENTS |
| WO2014071168A3 (en) | | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients |
| EA201291335A1 (en) | | PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION |
| CO2019004004A2 (en) | | Pharmaceutical composition and method for the treatment of non-alcoholic fatty liver disease |
| MX2016004909A (en) | | Composition containing eugenol as active ingredient for preventing or treating atopic dermatitis. |
| BR112015001627A2 (en) | | pharmaceutical composition, their uses and method of decreasing the frequency of urination |
| RU2013110517A (en) | | MEANS FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATHEPATITIS |
| BR112014033088A2 (en) | | a colitis prevention or treatment composition comprising s-allyl-1-cysteine as an active ingredient, and a medical preparation comprising it |
| TN2012000505A1 (en) | | Low-oil pharmaceutical emulsion compositions comprising progestogen |
| BR112014030288A2 (en) | | pharmaceutical composition |
| MX2013012038A (en) | | Combination of carotenoid, phytooestrogen and vitamin c for moisturizing the skin. |
| WO2011151786A3 (en) | | Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer |